Global Chromatography Solvents Market Analysis 2017-2024

Chromatography Solvents

Reliable lab equipment dealers supply chromatography solvents that support virtually every form of chromatography in common use. Such solvents are application-optimized and function-tested to enhance separation power and reproducibility. According to a recent Data Bridge Market Research report, the global Chromatography Solvents Market is expected to reach USD 3.56 billion by 2024 from USD 1.70 billion in 2016, at a CAGR of 9.5% in the forecast period 2017 to 2024.

Major factors fuelling the growth of this market include

  • high emphasis being given to environmental testing, pollution control, food safety, drug development and other biotechnology driven research
  • increased funding in healthcare, and
  • government grants for food safety and environmental protection

The global chromatography solvents market is segmented on the basis of product type, technology, application, end user and geography.

Product types in the market include polar solvents and non-polar solvents. The polar solvents segment is expected to dominate the market throughout the forecast period. Based on technology, the market is segmented into LCMS, HPLC, UPLC and GCMS, of which LC-MS solvents are expected to lead the market. On the basis of application, the market includes analytical and preparative chromatography, of which analytical application is predicted to dominate the market.

The end users of this market comprise industries such as pharmaceutical, biotechnology, academics and research, environmental, cosmetic, and food and beverages. The pharmaceutical segment is expected to dominate the global chromatography solvents market and is this trend is expected till 2024.

Key players operating in this market include EMD-Millipore, Avantor Performance Materials, Tedia Company, Inc., Regis Technologies, Inc., Thermo Fisher Scientific, Inc., VWR International, and Qualikems Fine Chem Pvt. Ltd. In 2016, Avantor Performance Materials and Thermo Fisher Scientific, Inc. hold the market share of 29.7% and 20.3%, respectively.

Additional Claim for Roche cobas Zika Test gets FDA Approval